Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2008
08/27/2008CN100413883C Peptidic compounds selectively binding to p-selectin
08/27/2008CN100413874C Novel water soluble Pt (II) anti-cancer ligand and its preparing method
08/27/2008CN100413834C Method for preparing compressible mannite particle
08/27/2008CN100413539C The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
08/27/2008CN100413535C Application of nerve growth factor in preparation of medicine for effective reducing body weight
08/27/2008CN100413529C Chinese medicinal composition for treating prostatitis and its preparation method
08/27/2008CN100413528C Chinese medicine for treating endometriosis and its preparing process
08/27/2008CN100413527C Iron bar spray of Tibetan medicine
08/27/2008CN100413526C Gastrointestinal health oral liquid and its preparing method
08/27/2008CN100413524C Spraying preparation of traditional Chinese medicine for recuperation of dermis after burns or scald, and its preparation method
08/27/2008CN100413523C Anal fistula treating Chinese medicine
08/27/2008CN100413521C Health product for reducing blood fat, and preparation method thereof
08/27/2008CN100413519C Camellia oil
08/27/2008CN100413516C Preparation of Chinese traditional medicine for curing fracture and preparation method
08/27/2008CN100413515C Chinese medicine composition for treating male's sterility and its preparation method
08/27/2008CN100413513C Medication for treating neonatal jaundice, and method of use
08/27/2008CN100413510C Mannosan peptide injection and preparation method thereof
08/27/2008CN100413506C Improved pharmaceutical compositions
08/27/2008CN100413505C Gel agent for treating glaucoma and its preparing process
08/27/2008CN100413504C Medicinal resin biological adhering slow-releasing liquid prepn. contg. aciclovir, and its preparation method
08/27/2008CN100413502C Hypertension treating medicine
08/27/2008CN100413501C Transdermal absorptive anemonin plaster
08/27/2008CN100413499C A nanoemulsion medicine of eugenol and preparation method thereof
08/27/2008CN100413498C Drop pills of soybean aglycone, and preparation method
08/27/2008CN100413497C Water soluble soybean aglycone medicinal composition and its preparing method
08/27/2008CN100413495C Medical use of 2 alpha, 3 beta-dihydroxy-5, 11(13)- diallyl eudesmane-12 acid for inhibiting hepatitis B virus
08/27/2008CN100413494C Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
08/27/2008CN100413492C Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
08/27/2008CN100413491C Sustained release preparation of solution resistant medicine
08/27/2008CN100413490C Insoluble medicine transdemal absorption preparation and process for preparing same
08/26/2008US7418374 Treatment protocol generation for diseases related to angiogenesis
08/26/2008US7417118 Pharmaceutical composition containing artificial oxygen carrier
08/26/2008US7417067 mixtures of bicyclic compounds such as lubiprostone, and triglycerides; bronchodilator agents; eye drops, capsules
08/26/2008US7417051 9,9-dimethyl-3-oxa-9-azoniumtricyclo(3.3.1.0(2,4))nonanyl 2,2-diphenylpropionate quaternary salt
08/26/2008US7417033 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
08/26/2008US7417022 Amino acid for deliverying active materials; bioavailability
08/26/2008US7417021 Biologically active conjugate of a biopolymer and therapeutic agent
08/26/2008US7417013 Warming and nonirritating lubricant compositions and method of comparing irritation
08/26/2008US7416740 Animal feed adjuvant
08/26/2008US7416739 Composition and process for retaining active ingredients
08/26/2008US7416738 Pharmaceutical pills comprising drugs such as non-steroidal antiinflammatory agents, and cores surrounded by shells, having apertures for timed or sustained drug delivery
08/26/2008US7416735 Mixture of emulsion and charged insoluble particles; topical applying to skin
08/26/2008US7416306 Laser projector
08/26/2008CA2490299C Pharmaceutical composition for controlled release of active substances and the manufacturing method thereof
08/26/2008CA2410446C Esmolol formulation
08/26/2008CA2403441C Antimicrobial bioabsorbable materials
08/26/2008CA2380071C Apparatus and methods for alternating laser treatment of pharmaceutical dispensers
08/26/2008CA2378487C Antibiotic(s)-polymer combination
08/26/2008CA2371200C Method for production of microcapsules
08/26/2008CA2360300C A transdermal composition of an antivomiting agent and a preparation containing the same
08/26/2008CA2348302C Suppositories comprising hydrophobic hydroxypropyl methylcellulose
08/26/2008CA2331465C Improvements relating to encapsulation of bioactive agents
08/26/2008CA2323810C Ophthalmic solution comprising glycogen
08/26/2008CA2292638C Composition comprising ketanserin and l-carnitine or an alkanoyl l-carnitine for the treatment of crps
08/26/2008CA2289761C Method of making microencapsulated dna for vaccination and gene therapy
08/26/2008CA2274773C Aqueous therapeutic agents of ibuprofen
08/26/2008CA2171550C Nucleosides with anti-hepatitis b virus activity
08/26/2008CA2160779C Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
08/26/2008CA2159602C Stable liquid compositions of gamma interferon
08/22/2008CA2617688A1 Solid dosage formulations containing weight-loss drugs
08/22/2008CA2579382A1 Controlled release delivery device
08/21/2008WO2008101214A2 Fixed drug ratios for treatment of hematopoietic cancers and proliferative disorders
08/21/2008WO2008101179A2 Use of sucrose to suppress mannitol-induced protein aggregation
08/21/2008WO2008101175A2 Protein formulations containing sorbitol
08/21/2008WO2008101173A2 Biodegradable compositions and materials
08/21/2008WO2008101139A1 Sustained-release tablet formulations of piperazine-piperidine antagonists and agonists of the 5-ht1a receptor having enhanced intestinal dissolution
08/21/2008WO2008101098A2 Use of botulinum toxin and enzymes for treating bladder or prostata disorders, or hyperhydrosis
08/21/2008WO2008101084A2 Methods and compositions for the disruption of biofilms
08/21/2008WO2008101076A1 Improved stability in vitamin and mineral supplements
08/21/2008WO2008101012A1 Use of ranolazine for the treatment of non-coronary microvascular diseases
08/21/2008WO2008101008A1 Use of ranolazine for the treatment of coronary microvascular diseases
08/21/2008WO2008101002A1 Use of ranolazine for the treatment of cardiovascular diseases
08/21/2008WO2008100992A1 Intravenous solutions comprising ranolazine
08/21/2008WO2008100876A1 Delivery devices containing encapsulated and/or particle-bound active pharmaceutical ingredients
08/21/2008WO2008100807A2 Ophthalmic compositions containing a synergistic combination of three polymers
08/21/2008WO2008100767A1 Compositions for improving gastrointestinal nutrient and drug absorption
08/21/2008WO2008100647A1 Therapeutic cooling pad for ophthalmologic and cosmetic use
08/21/2008WO2008100576A2 Sustained delivery formulations of rapamycin compounds
08/21/2008WO2008100482A2 Peptides that target to tumor blood vessels of lung cancer and applications thereof
08/21/2008WO2008100481A2 Lung cancer-targeted peptides and applications thereof
08/21/2008WO2008100434A1 Transoral dosage forms comprising sufentanil and naloxone
08/21/2008WO2008100375A2 Polymer-based films and drug delivery systems made therefrom
08/21/2008WO2008100262A1 Medicated feed premix comprising chlortetracycline hydrochloride
08/21/2008WO2008100249A1 Low flush niacin formulation
08/21/2008WO2008100240A2 Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
08/21/2008WO2008100202A1 A 2-f luorobenzoate salt and a 2, 6-dif luorobenzoate salt of n-{5-chloro-2- [ ( (2s) -3-{ [1- (4-chlorobenzyl)piperidin-4- yl ] amino } - 2 - hydroxy- 2 -me t hylpr opyl ) oxy] - 4 - hydroxyphenyl } acetamide
08/21/2008WO2008100107A1 Controlled-release preparation containing cilostazol and process for the preparation thereof
08/21/2008WO2008100106A1 Controlled release preparation containing cilostazoland process for the preparation thereof
08/21/2008WO2008100044A1 Chemically cross-linked hyaluronic acid hydrogel nanoparticles and the method for preparing thereof
08/21/2008WO2008100032A1 Thixotropic pharmaceutical compositions
08/21/2008WO2008099998A1 Orthopedic water-repellent stockinette and method of manufacturing the same
08/21/2008WO2008099911A1 Broad-spectrum antiviral composition having excellent storage stability
08/21/2008WO2008099835A1 Band seal for hard capsules having peg encapsulated therein
08/21/2008WO2008099800A1 Method for production of radiation diagnostic imaging agent
08/21/2008WO2008099742A2 Ejection liquid and ejection method
08/21/2008WO2008099615A1 Pharmaceutical composition containing fine particle oil-based suspension
08/21/2008WO2008099397A2 Compositions and methods for enhancing transmucosal delivery
08/21/2008WO2008099160A1 Solid oral dosage form containing bicalutamide and method of preparation
08/21/2008WO2008099084A1 Parenteral pharmaceutical composition and method for preparing the same
08/21/2008WO2008099068A2 Liquid anhydrous composition to be incorporated into the drinking water of cattle
1 ... 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 ... 2991